Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score

Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score

Appropriate administration of anti-inflammatory and immunosuppressive treatment (AIIST) is important for patients with Graves’ orbitopathy (GO). This study aimed to clarify the incidence and risk factors for GO treated with AIIST and propose a predictive score, among newly diagnosed Graves’ disease...

Full description

Saved in:
Bibliographic Details
Main Authors: Natsuko Watanabe, Jaeduk Yoshimura Noh, Ai Kozaki, Ran Yoshimura, Ai Yoshihara, Nami Suzuki, Masako Matsumoto, Miho Fukushita, Aya Kinoshita, Azusa Aida, Hideyuki Imai, Shigenori Hiruma, Toshu Inoue, Kosuke Inoue, Kiminori Sugino, Koichi Ito
Format: Article
Language:English
Published: The Japan Endocrine Society 2023-11-01
Series:Endocrine Journal
Subjects:
graves’ orbitopathy
graves’ disease
thyroid eye disease
tsh binding inhibitory immunoglobulin
thyroglobulin antibody
Online Access:https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0079/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0079/_html/-char/en

Similar Items